Discover
NRC
NRC Health
20.33
2 x 14.64
2 x 26.00
bid
ask
-
0.09
0.44%
2 @ 04:00 PM
20.33 +0.00 (0.00%)
| Ytd | 8.31% | |
| 1y | 73.46% |
20.01
day range
20.64
11.42
52 week range
22.77
| Open | 20.38 | Prev Close | 20.42 | Low | 20.01 | High | 20.64 | Mkt Cap | 450.09M |
| Vol | 52.56K | Avg Vol | 115.97K | EPS | 0.24 | P/E | 84.71 | Forward P/E | 15.38 |
| Beta | 0.53 | Short Ratio | 4.02 | Inst. Own | 52.02% | Dividend | 0.48 | Div Yield | 2.80 |
| Ex Div Date | 12-27 | Earning | 10-27 | 50-d Avg | 20.97 | 200-d Avg | 19.00 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 35.39M | ||
| Revenues (USD) | 35.39M | ||
| Cost of Revenue | 13.56M | ||
| Gross Profit | 21.83M | ||
| Operating Expenses | 25.07M | ||
| Selling, General and Administrative Expense | 22.95M | ||
| Operating Income | -3.24M | ||
| Interest Expense | 1.32M | ||
| Income Tax Expense | -1.25M | ||
| Net Income | -3.28M | ||
| Net Income Common Stock | -3.28M | ||
| Net Income Common Stock (USD) | -3.28M | ||
| Consolidated Income | -3.28M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Dividends per Basic Common Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -3.22M | ||
| Earning Before Interest & Taxes (USD) | -3.22M | ||
| Weighted Average Shares | 22.01M | ||
| Weighted Average Shares Diluted | 22.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.33M | ||
| Cash and Equivalents (USD) | 3.33M | ||
| Trade and Non-Trade Receivables | 9.32M | ||
| Current Assets | 22.81M | ||
| Property, Plant & Equipment Net | 39.50M | ||
| Total Assets | 136.15M | ||
| Debt Current | 4.02M | ||
| Total Debt | 90.03M | ||
| Current Liabilities | 35.02M | ||
| Debt Non-Current | 86.01M | ||
| Total Liabilities | 129.60M | ||
| Accumulated Retained Earnings (Deficit) | -24.51M | ||
| Shareholders Equity | 6.55M | ||
| Shareholders Equity (USD) | 6.55M | ||
| Assets Non-Current | 113.35M | ||
| Total Debt (USD) | 90.03M | ||
| Deferred Revenue | 16.72M | ||
| Goodwill and Intangible Assets | 68.26M | ||
| Liabilities Non-Current | 94.58M | ||
| Trade and Non-Trade Payables | 1.33M | ||
| Tax Assets | 4.33M | ||
| Tax Liabilities | 6.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.12M | ||
| Net Cash Flow from Financing | 718.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 780.00K | ||
| Capital Expenditure | -1.32M | ||
| Issuance (Purchase) of Equity Shares | -7.64M | ||
| Issuance (Repayment) of Debt Securities | 11.97M | ||
| Payment of Dividends & Other Cash Distributions | -3.61M | ||
| Net Cash Flow from Investing | -1.32M | ||
| Net Cash Flow from Operations | 1.39M | ||
| Share Based Compensation | 7.37M | ||